THERESA MOORE: Open Payments
NPI 1982687158 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 32 payments from 15 companies in 2025. Trend: 2023 $1,138 · 2024 $899 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| 180 Medical, Inc. | 7 | $135 |
| Antares Pharma, Inc. | 3 | $89 |
| Ferring Pharmaceuticals Inc. | 5 | $87 |
| Alnylam Pharmaceuticals Inc. | 3 | $78 |
| TOLMAR, INC. | 3 | $63 |
| ABBVIE INC. | 2 | $38 |
| Olympus America Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: GENTLECATH GLIDE, XYOSTED, ADSTILADRIN, GIVLAARI, JATENZO, GENTLECATH, BOTOX, iTIND System.
Industry payments across NY — which companies pay providers there.
